Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1282 (MIR1282) is a small, non-coding RNA molecule encoded by the human MIR1282 gene. It functions as a post-transcriptional regulator by binding to complementary sequences in targeted messenger RNAs, leading to repression of gene expression through mRNA degradation or translation inhibition. Like other microRNAs, MIR1282 is produced through the canonical microRNA biogenesis pathway, involving Drosha and Dicer processing, and is incorporated into the RNA-induced silencing complex (RISC) to mediate its effects. Although the specific biological and pathological roles of MIR1282 are not comprehensively characterized in the literature, the microRNA family as a whole is recognized for regulating processes such as cell proliferation, apoptosis, differentiation, and disease pathogenesis, including cancer.
For general microRNA-targeting drugs: Inhibition of miRNA maturation or function (using antisense oligonucleotides); miRNA sponges or decoys that competitively bind MIR1282, sequestering its activity; miRNA mimics to restore or replace MIR1282 function if lost.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1282 (MIR1282).